327 related articles for article (PubMed ID: 2199689)
1. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
Niida M; Yoshida T; Kohmoto A; Ogawa M; Hashimoto H; Deguchi K
Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267
[TBL] [Abstract][Full Text] [Related]
4. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
[TBL] [Abstract][Full Text] [Related]
5. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1991 Feb; 44(2):130-9. PubMed ID: 2041154
[TBL] [Abstract][Full Text] [Related]
6. [Effects of sulbactam on the activity of cefoperazone against various clinical isolates].
Uete T; Matsuo K
Jpn J Antibiot; 1989 Apr; 42(4):896-909. PubMed ID: 2769941
[TBL] [Abstract][Full Text] [Related]
7. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antibacterial activity of cefoperazone].
Watanabe Y; Minami S; Yotsuji A; Araki H; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3437-43. PubMed ID: 6609251
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Kazmierczak A; Siebor E; Acar JF; Denis F; Drugeon H; Fleurette J; Sirot J; Soussy CJ; Thabaut A
Pathol Biol (Paris); 1991 May; 39(5):384-90. PubMed ID: 1909015
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity of cefoperazone-sulbactam].
Zhang Y; Zhang J; Zhou L
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
[TBL] [Abstract][Full Text] [Related]
13.
Xiao S; Zhuo C; Zhuo C
Comput Math Methods Med; 2021; 2021():1175379. PubMed ID: 34868336
[TBL] [Abstract][Full Text] [Related]
14. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
Toyonaga Y; Kurosu Y; Nakamura H; Sugita M; Takahashi T; Hori M
Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740
[TBL] [Abstract][Full Text] [Related]
15. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
Uete T; Matsuo K
Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
[TBL] [Abstract][Full Text] [Related]
16. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
[TBL] [Abstract][Full Text] [Related]
17. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
18. [Laboratory and clinical study on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Hayashi I; Sakurai M; Ichiki M; Sekine I; Nakayama K; Shiotani J; Yoshida T; Niida M; Ogawa M; Koumoto A
Jpn J Antibiot; 1994 Jan; 47(1):29-39. PubMed ID: 8114271
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
